Needle-stick Injuries
Among Health Care
Workers

3/4/2014

1
1. Background of the Topic
2. Needle-stick injuries in
Ohud Hospital
Dr. Muhammad AL amin
Infection Control Coordinator

3/4/2014

2
What are Needle-stick injuries?





Wounds caused by needles.
Are hazard for the people.
Transmit infectious diseases.
Blood born viruses.

3/4/2014

3
Frequency











3/4/2014

Precise national data not available.
600 000 – 800 000 injuries / year occur in
USA.
½ of cases are not reported.
Injuries begun to decrease in USA.
Involve nursing staff, physicians and other
health workers.
Emotional impact can be sever.
4
Scope of the problem






3/4/2014

½ of all hepatitis B and C in some parts of
Africa and Asia due to contaminated sharps.
2/3 of hepatitis B and C in Eastern
Mediterranean due to contaminated sharps.
Over 2/3 of hepatitis B in Central and South
American due to occupational exposure.

5
Risk of Transmission of
Blood born Infection
Occupational
Exposure
Hepatitis B Virus
Hepatitis C Virus

2.7-10%

HIV

3/4/2014

Risk of
Transmission
2-40%

0.3% (1 in 300
chance of infection)
6
Factors which increase risk of
infection








3/4/2014

Deep injury.
Visible blood on the device.
High viral titer.
Artery or vein device.
Combined factors.
Un-immunized against hepatitis B.
No post exposure prophylaxis with Zidovidine
(prophylaxis decrease risk by 80%).
7
Hazards of Needle stick injuries










3/4/2014

Hepatitis B and C.
HIV.
Brucellosis.
Malaria.
S. aureus and S. pyogenes.
Toxoplasmosis.
Tuberculosis.

8
How common are needle stick
injuries?





Needle stick injuries (too common hazard).
Surgical instrument wound.
Mucus membranes.
Skin contact

3/4/2014

9
How do needle stick injuries
occur?



Their use, disassembly or disposal.
30 – 50% of injuries occur during clinical
procedures:
withdrawing a needle from a patient.
 Accessing IV line.





3/4/2014

During improper sharp disposal.
During clean-up.
Recapping: 25 – 30% of all injuries.
10
Conditions of work which
increase Needle stick injuries







Staff reductions.
Difficult patient care situations.
Reduced lighting.
New staff or students.
Needles are disposed improperly.
Emptying disposal containers.

3/4/2014

11
How can needle stick injuries be
prevented







3/4/2014

Employee training.
Recommended guidelines.
Safe recapping procedures.
Effective disposal systems.
Surveillance programs.
Improved equipment design.

12
Devices Involved in Percutaneous
Injuries


Hollow bore needle:
Hypodermic needle
 Winged-steel needle
 IV stylet
 Phlebotomy needle




Solid sharp:
Suture needle.
 Scalpel.


3/4/2014

13
Desirable Characteristic of
Devices with safety Features





The device is needleless.
The device is easy to use and practical.
The device is safe and performs reliably.
The safety feature is an integral part of the
device.

3/4/2014

14
What should the employers of
Health care implement.







Analyze needle stick injuries.
Proper training.
Promote safety awareness.
Establish procedures to encourage the
reporting.
Evaluate the effectiveness of prevention efforts

3/4/2014

15
Health care workers protection









3/4/2014

Use devices with safety features.
Avoid recapping needles.
Safe handling and disposal of medical
waste.
Report all needle stick injuries.
Follow recommended infection prevention
practices.
Participate in blood-born pathogen training.
16
Hospitals should
implement the followings:






Properly trained health care workers.
Encourage the reporting and timely follow up.
Promotion of safety awareness.
Analyze needle stick injuries to identify
hazards.

3/4/2014

17
3/4/2014

18
3/4/2014

19
Types of injuries
Needle stick injuries
Splash to skin and
mucus membrane

6 (16%)

Blades (Scalpel)

3/4/2014

28 (74%)

4 (10%)

20
Departments
ICU
Operating Room
(OR)

5 (13)

Medical Wards

4 (10%)

Surgical Wards

4 (10%)

Gynecology and
Obstetrics
Pediatrics and
Nursery

3 (8%)

Others
3/4/2014

15 (39%)

5 (15%)

2 (5%)

21
State of Vaccination





3/4/2014

31 of 38 (81%) were vaccinated for
Hepatitis B.
2 needed booster doses.
5 of 38 (13 %) were not
vaccinated.

22
Blood Born Diseases in sera
of patients
Hepatitis B

9 (24%)

Hepatitis C

7 (18%)

Not Known

20 (58%)

3/4/2014

23
Time of reporting
Same day
After 1 day

13 (34%)

After 2 days

5 (13%)

After 3 days

3 (9%)

> 3 days

2 (5%)

Not recorded

3/4/2014

11 (29%)

4 (11%)

24
What is the message of this
Surveillance?





3/4/2014

Rate of the needle stick injuries is known.
Search for factors that cause the injuries.
Should receive proper treatment.
Identify areas in which the prevention
program need improvement.

25
Conclusion




3/4/2014

Ensure that health care workers are properly
trained in the safe use and disposable needles.
Encourage the reporting and timely follow up of
all needle stick injuries.

26
3/4/2014

27
HIV Post-Exposure Prophylaxis (cont.)


Basic regimen:

zidovudine (AZT) 300mg bid + lamivudine (3TC) 150mg bid
x 28 days



Expanded regimen:
Basic regimen

+

Kaletra (lopinavir/ritonovir)
{or atazanavir (Reyataz)
or indinavir (Crixivan)
or nelfinavir (Viracept)
or efavirenz (Sustiva)}
x 28 days
HIV Post-Exposure Prophylaxis


Initiate PEP as soon as possible, preferably within 2 hours of
exposure.



Offer pregnancy testing to all women of childbearing age not
known to be pregnant.



Seek expert consultation if viral resistance is suspected.



Administer PEP for 4 weeks if tolerated.
Hepatitis C




Perform baseline and follow-up testing for anti-HCV and alanine
aminotransferase (ALT) 4 – 6 months after exposure.
Perform HCV RNA at 4 – 6 weeks if earlier diagnosis of HCV
infection desired.



Confirm repeatedly reactive anti-HCV results with supplemental
tests.



Post-exposure prophylaxis (PEP) not recommended.






Perform follow-up anti-HBs testing in persons who
receive hepatitis vaccine.
Test for anti-HBs 1 – 2 months after last dose of
vaccine.
Anti-HBs response to vaccine cannot be ascertained if
HBIG was received in the previous 3 – 4 months.
Recommended PEP for exposure to HBV
Vaccination and
antibody response
status of exposed
workers

Source HBsAg
positive

Source HBsAg
negative

Source unknown or
unavailable for testing

HBIG x 1 and initiate
HB vaccine series

Initiate HB vaccine
series

Initiate HB vaccine
series

No treatment

No treatment

No treatment

-known non-responder

HBIG x 1 and initiate
revaccination
or HBIG x 2

No treatment

If known high risk
source, treat as if
source HBsAg positiive

Antibody response
unknown

Test exposed person. No treatment
No treatment if HBsAb
positive.
If inadequate antibody
titer, administer HBIG
x1 and vaccine
booster

Unvaccinated
Previously vaccinated
- known responder

Test exposed person for
HBsAb. No treatment if
HBsAb positive.
If inadequate antibody
titer, administer vaccine
booster and re-check
titer in 1 – 2 month

14 needle-stick injuries among health care workers

  • 1.
    Needle-stick Injuries Among HealthCare Workers 3/4/2014 1
  • 2.
    1. Background ofthe Topic 2. Needle-stick injuries in Ohud Hospital Dr. Muhammad AL amin Infection Control Coordinator 3/4/2014 2
  • 3.
    What are Needle-stickinjuries?     Wounds caused by needles. Are hazard for the people. Transmit infectious diseases. Blood born viruses. 3/4/2014 3
  • 4.
    Frequency       3/4/2014 Precise national datanot available. 600 000 – 800 000 injuries / year occur in USA. ½ of cases are not reported. Injuries begun to decrease in USA. Involve nursing staff, physicians and other health workers. Emotional impact can be sever. 4
  • 5.
    Scope of theproblem    3/4/2014 ½ of all hepatitis B and C in some parts of Africa and Asia due to contaminated sharps. 2/3 of hepatitis B and C in Eastern Mediterranean due to contaminated sharps. Over 2/3 of hepatitis B in Central and South American due to occupational exposure. 5
  • 6.
    Risk of Transmissionof Blood born Infection Occupational Exposure Hepatitis B Virus Hepatitis C Virus 2.7-10% HIV 3/4/2014 Risk of Transmission 2-40% 0.3% (1 in 300 chance of infection) 6
  • 7.
    Factors which increaserisk of infection        3/4/2014 Deep injury. Visible blood on the device. High viral titer. Artery or vein device. Combined factors. Un-immunized against hepatitis B. No post exposure prophylaxis with Zidovidine (prophylaxis decrease risk by 80%). 7
  • 8.
    Hazards of Needlestick injuries        3/4/2014 Hepatitis B and C. HIV. Brucellosis. Malaria. S. aureus and S. pyogenes. Toxoplasmosis. Tuberculosis. 8
  • 9.
    How common areneedle stick injuries?     Needle stick injuries (too common hazard). Surgical instrument wound. Mucus membranes. Skin contact 3/4/2014 9
  • 10.
    How do needlestick injuries occur?   Their use, disassembly or disposal. 30 – 50% of injuries occur during clinical procedures: withdrawing a needle from a patient.  Accessing IV line.     3/4/2014 During improper sharp disposal. During clean-up. Recapping: 25 – 30% of all injuries. 10
  • 11.
    Conditions of workwhich increase Needle stick injuries       Staff reductions. Difficult patient care situations. Reduced lighting. New staff or students. Needles are disposed improperly. Emptying disposal containers. 3/4/2014 11
  • 12.
    How can needlestick injuries be prevented       3/4/2014 Employee training. Recommended guidelines. Safe recapping procedures. Effective disposal systems. Surveillance programs. Improved equipment design. 12
  • 13.
    Devices Involved inPercutaneous Injuries  Hollow bore needle: Hypodermic needle  Winged-steel needle  IV stylet  Phlebotomy needle   Solid sharp: Suture needle.  Scalpel.  3/4/2014 13
  • 14.
    Desirable Characteristic of Deviceswith safety Features     The device is needleless. The device is easy to use and practical. The device is safe and performs reliably. The safety feature is an integral part of the device. 3/4/2014 14
  • 15.
    What should theemployers of Health care implement.      Analyze needle stick injuries. Proper training. Promote safety awareness. Establish procedures to encourage the reporting. Evaluate the effectiveness of prevention efforts 3/4/2014 15
  • 16.
    Health care workersprotection       3/4/2014 Use devices with safety features. Avoid recapping needles. Safe handling and disposal of medical waste. Report all needle stick injuries. Follow recommended infection prevention practices. Participate in blood-born pathogen training. 16
  • 17.
    Hospitals should implement thefollowings:     Properly trained health care workers. Encourage the reporting and timely follow up. Promotion of safety awareness. Analyze needle stick injuries to identify hazards. 3/4/2014 17
  • 18.
  • 19.
  • 20.
    Types of injuries Needlestick injuries Splash to skin and mucus membrane 6 (16%) Blades (Scalpel) 3/4/2014 28 (74%) 4 (10%) 20
  • 21.
    Departments ICU Operating Room (OR) 5 (13) MedicalWards 4 (10%) Surgical Wards 4 (10%) Gynecology and Obstetrics Pediatrics and Nursery 3 (8%) Others 3/4/2014 15 (39%) 5 (15%) 2 (5%) 21
  • 22.
    State of Vaccination    3/4/2014 31of 38 (81%) were vaccinated for Hepatitis B. 2 needed booster doses. 5 of 38 (13 %) were not vaccinated. 22
  • 23.
    Blood Born Diseasesin sera of patients Hepatitis B 9 (24%) Hepatitis C 7 (18%) Not Known 20 (58%) 3/4/2014 23
  • 24.
    Time of reporting Sameday After 1 day 13 (34%) After 2 days 5 (13%) After 3 days 3 (9%) > 3 days 2 (5%) Not recorded 3/4/2014 11 (29%) 4 (11%) 24
  • 25.
    What is themessage of this Surveillance?     3/4/2014 Rate of the needle stick injuries is known. Search for factors that cause the injuries. Should receive proper treatment. Identify areas in which the prevention program need improvement. 25
  • 26.
    Conclusion   3/4/2014 Ensure that healthcare workers are properly trained in the safe use and disposable needles. Encourage the reporting and timely follow up of all needle stick injuries. 26
  • 27.
  • 28.
    HIV Post-Exposure Prophylaxis(cont.)  Basic regimen: zidovudine (AZT) 300mg bid + lamivudine (3TC) 150mg bid x 28 days  Expanded regimen: Basic regimen + Kaletra (lopinavir/ritonovir) {or atazanavir (Reyataz) or indinavir (Crixivan) or nelfinavir (Viracept) or efavirenz (Sustiva)} x 28 days
  • 29.
    HIV Post-Exposure Prophylaxis  InitiatePEP as soon as possible, preferably within 2 hours of exposure.  Offer pregnancy testing to all women of childbearing age not known to be pregnant.  Seek expert consultation if viral resistance is suspected.  Administer PEP for 4 weeks if tolerated.
  • 30.
    Hepatitis C   Perform baselineand follow-up testing for anti-HCV and alanine aminotransferase (ALT) 4 – 6 months after exposure. Perform HCV RNA at 4 – 6 weeks if earlier diagnosis of HCV infection desired.  Confirm repeatedly reactive anti-HCV results with supplemental tests.  Post-exposure prophylaxis (PEP) not recommended.
  • 31.
       Perform follow-up anti-HBstesting in persons who receive hepatitis vaccine. Test for anti-HBs 1 – 2 months after last dose of vaccine. Anti-HBs response to vaccine cannot be ascertained if HBIG was received in the previous 3 – 4 months.
  • 32.
    Recommended PEP forexposure to HBV Vaccination and antibody response status of exposed workers Source HBsAg positive Source HBsAg negative Source unknown or unavailable for testing HBIG x 1 and initiate HB vaccine series Initiate HB vaccine series Initiate HB vaccine series No treatment No treatment No treatment -known non-responder HBIG x 1 and initiate revaccination or HBIG x 2 No treatment If known high risk source, treat as if source HBsAg positiive Antibody response unknown Test exposed person. No treatment No treatment if HBsAb positive. If inadequate antibody titer, administer HBIG x1 and vaccine booster Unvaccinated Previously vaccinated - known responder Test exposed person for HBsAb. No treatment if HBsAb positive. If inadequate antibody titer, administer vaccine booster and re-check titer in 1 – 2 month